EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Admission ferritin in STEMI predicts long-term major adverse cardiovascular outcomes

David Alberto Brenes-Castro iD, Jorge Arturo Ortega-Hernández, Ximena Latapi-Ruíz Esparza, Jorge Daniel Sierra-Lara Martínez, José Luis Briseno-De La Cruz, Héctor González-Pacheco, Rodrigo Gopar-Nieto, Alexandra Arias-Mendoza iD, Diego Araiza-Garaygordobil iD

European Heart Journal Open · 01.07.2026 · 6 (4)

DOI: 10.1093/ehjopen/oeag092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Heart Journal Open, online erschienen am 09.06.2026. Verfasst von David Alberto Brenes-Castro und 8 weiteren Autor:innen. Beteiligte Einrichtung: Universidad Nacional Autónoma de México, Mexico City 04510, Mexico. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Inflammation is a key driver of atherosclerosis and acute coronary syndromes (ACS). Despite the prognostic relevance of inflammatory biomarkers in STEMI, the role of serum ferritin, an inflammation-sensitive marker of iron metabolism, remains unclear. The purpose of this study is to evaluate the association between elevated ferritin (≥300 ng/mL) and long-term major adverse cardiovascular events (MACE) in patients with STEMI. Methods and results This is a substudy of the PHASE-MX registry, a prospective cohort of STEMI patients treated at our institution (2018–2021). Patients ≥18 years old with ferritin measurement at admission were included. The primary outcome was MACE [all-cause mortality, cardiogenic shock, recurrent myocardial infarction, and new-onset congestive heart failure (CHF)]. A total of 477 patients were included with a follow-up of 4.5 years (median of 533 days, IQR 338–1137). Median age was 59, 45.4% had hypertension, and 34.9% had diabetes. No differences in baseline characteristics were found among groups. Ferritin ≥300 ng/mL was present in 29.9% of patients and was associated with a higher risk of MACE (HR 1.43, 95% CI 1.06–1.94; P = 0.01), driven by all-cause mortality (HR 2.00, 95% CI 1.09–3.69) and new CHF (HR 1.46, 95% CI 1.05–2.04). This association remained significant after adjustment for inflammatory markers and GRACE score (aHR 1.48, 95% CI 1.04–2.10; P = 0.02).

Conclusion

Elevated ferritin (≥300 ng/mL) is an independent predictor of long-term MACE in STEMI, supporting its potential role as a prognostic biomarker in ACS.

Schlagwörter

Stichwörter der Autor:innen

FerritinInflammationIron deficiencyMACEPrognosisSTEMI

Autor:innen und Institutionen

  • Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
  • Coronary Care Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico.

ORCID-Profile: David Alberto Brenes-Castro, Alexandra Arias-Mendoza, Diego Araiza-Garaygordobil

Zitieren

APA

Brenes-Castro, D. A., Ortega-Hernández, J. A., Latapi-Ruíz Esparza, X., Sierra-Lara Martínez, J. D., Briseno-De La Cruz, J. L., González-Pacheco, H., Gopar-Nieto, R., Arias-Mendoza, A., & Araiza-Garaygordobil, D. (2026). Admission ferritin in STEMI predicts long-term major adverse cardiovascular outcomes. European Heart Journal Open, 6(4). https://doi.org/10.1093/ehjopen/oeag092

Vancouver

Brenes-Castro DA, Ortega-Hernández JA, Latapi-Ruíz Esparza X, Sierra-Lara Martínez JD, Briseno-De La Cruz JL, González-Pacheco H, et al. Admission ferritin in STEMI predicts long-term major adverse cardiovascular outcomes. European Heart Journal Open. 2026;6(4). doi:10.1093/ehjopen/oeag092

BibTeX
@article{BrenesCastro2026,
  author = {Brenes-Castro, David Alberto and Ortega-Hernández, Jorge Arturo and Latapi-Ruíz Esparza, Ximena and Sierra-Lara Martínez, Jorge Daniel and Briseno-De La Cruz, José Luis and González-Pacheco, Héctor and Gopar-Nieto, Rodrigo and Arias-Mendoza, Alexandra and Araiza-Garaygordobil, Diego},
  title = {Admission ferritin in STEMI predicts long-term major adverse cardiovascular outcomes},
  journal = {European Heart Journal Open},
  year = {2026},
  volume = {6},
  number = {4},
  doi = {10.1093/ehjopen/oeag092}
}
Kostenlos starten →